KATO MEDICAL ApS: Financial statements 2022
CVR: 30703391
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
KATO MEDICAL ApS (CVR 30703391) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -29,839 and a net result of DKK 73,491 compared with DKK 176,863 the year before. Equity in the 2022 report amounted to DKK 1,771,283. The solvency ratio was 99.3%.
- Gross Profit
- DKK -29,839
- Profit/Loss
- DKK 73,491
- Equity
- DKK 1,771,283
- Total Assets
- DKK 1,783,283
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -30K | 73K | 1.8M | - |
| 2021 | - | -15K | 177K | 2M | - |
| 2020 | - | -17K | 419K | 2.1M | - |
| 2019 | - | -14K | 19K | 1.7M | - |
| 2018 | - | -23K | -969K | 1.9M | - |
Official annual report
Keep an eye on KATO MEDICAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
KATO MEDICAL ApS has published its annual report for 2021. Gross profit came to DKK -15,319, and the net result was DKK 176,863.
About KATO MEDICAL ApS
KATO MEDICAL ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2007. The company is registered under the industry Speciallægers aktiviteter. The management consists of Karsten Thomsen and Tove Birkebæk Thomsen. The company's owners include Karsten Thomsen, Tove Birkebæk Thomsen and Frederik Ferløv Thomsen. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -35,921 and a net result of DKK -687,381 compared with DKK -202,605 the year before. Equity in the 2025 report amounted to DKK 750,693.
